| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_cf18e1fee4c0021271f8ae66c64c5838
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_dce401cb00047d8f6388df5d87bcfbb0
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_44fbe5b02d661b2a28cfb2187a78afce
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_264bf352e117497b6fb6950f7e10af26
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_e1005fb53db203969fab84a916931d38
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_07d5dcbb9f91a44c19e14317e706f590 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-156
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2021-3595 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N21-3563
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-6886
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-68 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-68 |
| filingDate |
2015-11-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_862face5561aa685b207168950ef863d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6df717cbfc4fe3c9800b2e0297bd1b19
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_28e5b1e28ca9760b9f1ff56857f1279d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_67a7252a326d1b3a7e5cda3113b6c325
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8ae98c9b365cf869957d0501bb163c60 |
| publicationDate |
2017-09-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
EP-3215636-A1 |
| titleOfInvention |
Method for identifying in a subject tumour cells bearing a t315i mutation |
| abstract |
The present invention relates to a method for identifying in a human subject sample a cell as being a tumour cell from chronic myeloid leukaemia bearing a T315I mutation, comprising the steps consisting in: - passing a beam of infrared light through a bone marrow cell sample or a blood nonnucleated cell sample in vitro according to micro Fourier Transformed infrared microspectroscopy (FTIR) which produces a vibrational spectrum in the wavelength range of 22222.2 nm to 2500 nm, and therefore obtaining a first vibrational spectrum, - comparing the first vibrational spectrum to a reference vibrational spectrum obtained by FTIR on reference cells from chronic myeloid leukaemia without T3151 mutation, - identifying the sample cells as being tumour cells from chronic myeloid leukaemia bearing a T315I mutation if a difference in composition or band shape between the reference vibrational spectrum and the first vibrational spectrum is noticed. |
| priorityDate |
2014-11-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |